BioSpace News Archive

Carrier delivers the gift of travel for medical patients and their caregivers; linking essential health care services through organizations across North America

eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance exchange in the United States, announced today that the company plans to release fourth quarter and fiscal year 2019 financial results on February 20, 2020.

Simon Greenstone Panatier trial lawyer: Jury’s large punitive award sends message [07-February-2020] NEW BRUNSWICK, N.J. , Feb. 7, 2020 /PRNewswire/ -- A New Jersey jury has ordered Johnson & Johnson (NYSE:JNJ) to pay $750 million in punitive damages to four cancer victims who charged that the company’s iconic Johnson’s Baby Powder contained cancer-causing a

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is an accessory to compatible diagnostic ultrasound systems and uses artificial intelligence to help the user

CooperCompanies announced that Mark Drury has been appointed Vice President, General Counsel and Corporate Secretary effective February 15, 2020, reporting to Albert G. White, President and Chief Executive Officer.

Feb. 7, 2020 21:30 UTC The addition of three lab locations complements Zoetis’ growing reference laboratory footprint and enhances its value to veterinarians in the U.S. PARSIPPANY, N.J. & WOBURN, Mass.--( BUSINESS WIRE )-- Zoetis Inc . (NYSE:ZTS) today announced the acquisition of Ethos Diagnostic Science, a veterinary reference lab business dedicated to serving leading specialty animal hospitals, the greater veterinary community and researchers with accurate, reliabl

Shields provides specialty pharmacy services to hospitals and other covered entities. On October 24, 2019, Shields learned of suspicious activity related to an employee’s email account.

The Phantom® ActivCore Nail addresses TTC arthrodesis and is the second of three hindfoot fusion nailing systems Paragon 28® plans to launch in 2020.

February 7, 2020, JDC Healthcare Management (“JDC”) began notifying patients of a recent incident impacting the privacy of certain information.

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that, at its Special Meeting of Shareholders (the “Special Meeting”), based on a preliminary vote count provided by the Company’s proxy solicitor, OncoSec shareholders have approved the proposed strategic investment by and partnership (the “CGP/Sirtex Transaction”)